DNA Repair Mechanisms as Targets for Therapy of Pituitary Adenomas

This entry was posted in Research Projects on by .

Edward Laws, MD

TMZ is the first new drug of the past 30 years that aggressively and effectively treats malignant gliomas and improves the quality of life for patients. Dr. Edward Laws, seeing the tremendous potential of this treatment, has embarked on a study investigating the use of TMZ on aggressive and malignant pituitary tumors when standard therapies fail.

Promising results are already being reported, and Dr. Laws hopes that this novel approach will pave the way for similar investigations into other types of primary brain tumors.